
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Psychiatry , 14 February 2022
Sec. Psychological Therapy and Psychosomatics
Volume 13 - 2022 | https://doi.org/10.3389/fpsyt.2022.837357
This article is a correction to:
The LIFEwithIBD Intervention: Study Protocol for a Randomized Controlled Trial of a Face-to-Face Acceptance and Commitment Therapy and Compassion-Based Intervention Tailored to People With Inflammatory Bowel Disease
by Trindade, I. A., Pereira, J., Galhardo, A., Ferreira, N. B., Lucena-Santos, P., Carvalho, S. A., Oliveira, S., Skvarc, D., Rocha, B. S., Portela, F., and Ferreira, C. (2021). Front. Psychiatry 12:699367. doi: 10.3389/fpsyt.2021.699367
In the original article, Figure 1 was not correctly presented. The participant flow was not correctly calculated and reported, in particular to what concerned the number of participants from the experimental group with complete baseline assessments. This mistake was identified in the beginning of the conduction of the RCT's statistical analyses, after the present study protocol was published. The flow diagram has been updated and re-designed according to CONSORT 2010 guidelines. The corrected Figure 1 appears below.
Figure 1. CONSORT 2010 flow diagram. *Participants with three consecutive absences or who attended less than two-thirds of the intervention were considered non-completers.
In the paragraph “Randomization of Participants”, the information provided in the last sentence was incomplete. As originally reported, before the start of the intervention, six patients self-excluded from the study due to a lack of resources to attend the sessions (e.g., lack of time, transportation). In addition to these participants, other 6 participants also dropped out from the study without providing a reason. A correction has been made to this paragraph:
Randomization of Participants
Figure 1 shows the flow of participants through the study. Of the 355 patients screened, 279 were excluded for not meeting criteria to participate. Seventy-six participants were randomly assigned to one of two conditions: experimental group (Treatment as Usual + LIFEwithIBD intervention: n = 38) or control group (TAU: n = 38), through computed-based randomization (www.random.org/lists/). Before the start of the intervention, twelve participants self-excluded from the study; half provided reasons for dropping out, such as lack of time, lack of transportation, or unavailability due to overlapping schedules.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: acceptance and commitment therapy, compassion, inflammatory bowel disease, mindfulness, randomized controlled trial, study protocol
Citation: Trindade IA, Pereira J, Galhardo A, Ferreira NB, Lucena-Santos P, Carvalho SA, Oliveira S, Skvarc D, Rocha BS, Portela F and Ferreira C (2022) Corrigendum: The LIFEwithIBD Intervention: Study Protocol for a Randomized Controlled Trial of a Face-to-Face Acceptance and Commitment Therapy and Compassion-Based Intervention Tailored to People With Inflammatory Bowel Disease. Front. Psychiatry 13:837357. doi: 10.3389/fpsyt.2022.837357
Received: 16 December 2021; Accepted: 14 January 2022;
Published: 14 February 2022.
Edited and reviewed by: Georgios Paslakis, Ruhr University Bochum, Germany
Copyright © 2022 Trindade, Pereira, Galhardo, Ferreira, Lucena-Santos, Carvalho, Oliveira, Skvarc, Rocha, Portela and Ferreira. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Inês A. Trindade, aW5lcy5hbG1laWRhdHJpbmRhZGVAZ21haWwuY29t; Cláudia Ferreira, Y2xhdWRpYWZlcnJlaXJhQGZwY2UudWMucHQ=
†These authors share first authorship
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.